Diagnostics Solutions Strategic Priorities

Diagnostics solutions: Strategic priorities Achieving differentiation based on four distinct pillars + Medical value Diagnostics efficiency Digitalization Address top disease areas and unmet clinical needs Drive integration & connectivity from labs to patients Digitalize lab operations and test interpretation Examples of success FDA BDD FDA Molecular Lab & Core Lab, Point of Care: 9 FDA Breakthrough Device Designations since 2018 1 Product to be launched in 2021 Molecular Lab: Point of Care: cobasⓇ prime cobasⓇ pulse¹ Pathology Lab: uPath Software Point of Care: v-TAC Software Market access Ensure access to novel diagnostics Roche Molecular & Pathology Lab: Cervical Cancer Screening Core Lab: Pre-eclampsia in guidelines 23 23

View entire presentation